Skip to content

Clinical trials

Completed Phase 2 Hemophilia A trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 2 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20071
20081
20091
20103
20141
20173
20182
20201
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
CSL Behring2
Novo Nordisk A/S2
Staidson (Beijing) Biopharmaceuticals Co., Ltd2
Carelon Research1
Gilead Sciences1
Hangzhou Gensciences Biopharmaceutical Co., Ltd.1
Kiminori Kimura, MD1
Medical University of Vienna1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A22
Hemophilia B2
von Willebrand Diseases2
HIV Infections1
Hemorrhage1
Hemostatic Disorders1
Hepatitis1
Hepatitis C1
Liver Cirrhosis1
Renal Insufficiency1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.